Table 1.
Outcome | Data source | Cases (n) | Controls (n) | Population |
---|---|---|---|---|
Lung cancer | ILCCO | 11,348 | 15,861 | European |
Ovarian cancer | OCAC | 25,509 | 40,941 | European |
Endometrial carcinoma | Consortium (Tracy et al.) | 12,906 | 108,979 | European |
Breast cancer | BCAC | 46,785 | 42,892 | European |
Kidney cancer | The FinnGen consortium | 971 | 174,006 | European |
Gastric cancer | The FinnGen consortium | 633 | 174,006 | European |
Prostate cancer | PRACTICAL | 79,148 | 61,106 | European |
Skin malignancy | The FinnGen consortium | 10,384 | 208,408 | European |
Oropharyngeal cancer | Consortium (Corina et al.) | 2,497 | 2,928 | European |
ILCCO, International Lung Cancer Consortium; OCAC, Ovarian Cancer Alliance Consortium; BCAC, Breast Cancer Association Consortium; PRACTICAL, Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome Consortium.